![](/img/cover-not-exists.png)
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes
Home, Philip, Ravi Shankar, R., Gantz, Ira, Iredale, Carol, O'Neill, Edward A., Jain, Lokesh, Pong, Annpey, Suryawanshi, Shailaja, Engel, Samuel S., Kaufman, Keith D., Lai, EsengLanguage:
english
Journal:
Diabetes Research and Clinical Practice
DOI:
10.1016/j.diabres.2017.10.018
Date:
October, 2017
File:
PDF, 993 KB
english, 2017